Does anyone think their tech upside has been priced into the stock already? I'm excited by the prospect of new streams of revenue from patient monitoring etc, but with markets how they currently are, feels like the share price isn't reacting much to revenue growth
Ann: Second quarter revenue growth of 17% to $21.4 million, page-4
Add SOM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $74.55M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.5¢ | 34.0¢ | $18.85K | 54.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 2868 | 1 |
View Market Depth
| Last trade - 14.48pm 19/07/2024 (20 minute delay) ? |
| SOM (ASX) Chart |